Specific IgE Response and Omalizumab Responsiveness in Severe Allergic Asthma

OBJECTIVE: Omalizumab has demonstrated clinical efficacy in patients with severe allergic asthma sensitized to perennial allergens and/or severe pollinosis through inhibition of IgE-dependent allergic response. When considering the “one airway, one disease” concept, sensitization to pollen could pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajiri, Tomoko, Suzuki, Motohiko, Kutsuna, Takeo, Nishiyama, Hirono, Ito, Keima, Takeda, Norihisa, Fukumitsu, Kensuke, Kanemitsu, Yoshihiro, Fukuda, Satoshi, Umemura, Takehiro, Ohkubo, Hirotsugu, Maeno, Ken, Ito, Yutaka, Oguri, Tetsuya, Takemura, Masaya, Yoshikawa, Kosho, Niimi, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879023/
https://www.ncbi.nlm.nih.gov/pubmed/36714051
http://dx.doi.org/10.2147/JAA.S393683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879023/
https://www.ncbi.nlm.nih.gov/pubmed/36714051
http://dx.doi.org/10.2147/JAA.S393683

Ejemplares similares